Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v4-FR
Language French French
Date Updated 2018-02-15 2017-10-23
Drug Identification Number 02282259 02282259
Brand name MYLAN-RISPERIDONE MYLAN-RISPERIDONE
Common or Proper name RISPERIDONE RISPERIDONE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients RISPERIDONE RISPERIDONE
Strength(s) 0.50MG 0.50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100BT 100BT
ATC code N05AX N05AX
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-02-02 2018-02-02
Actual discontinuation date 2018-02-01
Remaining supply date 2018-02-02 2018-02-02
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Last Lot # 3054049 and Expires 30-Apr-18. Resolved/Discontinued in ID 26702
Health Canada comments